Catheter News and Research

RSS

In medicine, a catheter is a tube that can be inserted into a body cavity, duct, or vessel. Catheters . In most uses, a catheter is a thin, flexible tube ("soft" catheter), though in some uses, it is a larger, solid ("hard") catheter. A catheter left inside the body, either temporarily or permanently, may be referred to as an indwelling catheter. A permanently inserted catheter may be referred to as a permcath.

Helen DeVos Children's Hospital uses two imaging techniques to produce hybrid 3D model of a patient's heart

Congenital heart experts from Spectrum Health Helen DeVos Children's Hospital have successfully integrated two common imaging techniques to produce a three-dimensional anatomic model of a patient's heart.

27 Jun 2015

Daily CHG bathing protocol for pediatric patients reduces bloodstream infections by 59%: Study

Daily bathing of pediatric patients with disposable cloths containing 2 percent chlorhexidine gluconate (CHG) reduced central line-associated bloodstream infections (CLABSIs) by 59 percent and saved approximately $300,000 in one hospital over a six-month period, according to a new study.

27 Jun 2015

Uninterrupted NOAC treatment during catheter ablation of atrial fibrillation is safe, shows research

Uninterrupted treatment with novel oral anticoagulants (NOACs) during catheter ablation of atrial fibrillation (AF) is safe, reveals research presented today at EHRA EUROPACE - CARDIOSTIM 2015 by Dr Carsten Wunderlich, senior consultant in the Department of Invasive Electrophysiology, Heart Centre Dresden, Germany.

25 Jun 2015

Study reveals how geography affects the survival of people with end-stage kidney disease

The notion that geography often shapes economic and political destiny has long informed the work of economists and political scholars. Now a study led by medical scientists at Johns Hopkins reveals how geography also appears to affect the very survival of people with end-stage kidney disease in need of dialysis.

24 Jun 2015

DC Devices announces completion of enrollment in REDUCE LAP-HF trial for diastolic heart failure treatment

DC Devices, Inc., a medical device company pioneering first-in-class structural heart devices for heart failure, today announced that it has completed enrollment and implants in the REDUCE LAP-HF trial, an open label, multi-center, single-arm study of the InterAtrial Shunt Device (IASD) – the world's first transcatheter device for the treatment of diastolic heart failure (DHF), which is also known as heart failure with preserved ejection fraction (HFpEF).

22 Jun 2015

Accurexa seeks FDA clearance to market BranchPoint device

Accurexa Inc., a biotechnology company focused on developing and commercializing novel neurological therapies, announced on Monday that it has filed a submission with the U.S. FDA for 510(k) clearance to market its BranchPoint device.

17 Jun 2015

Completing sepsis resuscitation bundle in six hours after diagnosis

Blood poisoning, known as sepsis, is the most common cause of death in intensive care units, according to the National Institutes of Health. The body's immune response to fight the infection triggers inflammation that restricts blood flow and leads to multiple organ failure.

17 Jun 2015

FDA grants Fast Track designation to Juventas' JVS-100 drug candidate and allows Phase 2b clinical trial

Juventas Therapeutics, Inc., a clinical-stage biotechnology company developing novel non-viral gene therapies that activate natural processes to repair the body, today announced that its product candidate, JVS-100, received Fast Track designation from the U.S. Food and Drug Administration for the treatment of advanced ischemic chronic heart failure.

16 Jun 2015

Nutrinia's NTRA-9620 granted FDA orphan drug designation for treatment of short bowel syndrome

Nutrinia, developing therapies to treat rare gastrointestinal disorders, announced today that the U.S. Food and Drug Administration (FDA) granted orphan drug designation for the company's orally-administered drug for treating short bowel syndrome (SBS) in patients of all ages. Nutrinia plans to begin a pivotal clinical trial in this indication.

15 Jun 2015

Paediatric outpatient study compares effectiveness of three alternative treatments for type 1 diabetes

A Montréal research team, co-supervised by Dr. Rémi Rabasa-Lhoret from the IRCM and Dr. Laurent Legault from the Montreal Children's Hospital, undertook the first paediatric outpatient study to compare three alternative treatments for type 1 diabetes.

11 Jun 2015

Re-Inflating balloon after carotid stenting appears to double risk of stroke and death

Patients with severe blockages typically undergo surgery to scrape off the fatty deposits from the walls of the vessel, the preferred approach that carries notably lower stroke risk but is not recommended for people too sick to withstand traditional surgery...

4 Jun 2015

El Camino Hospital enrolls first patient in safety study using RenovoCath

El Camino Hospital in Mountain View, California has enrolled the first patient in a safety study using the RenovoCath, a new catheter that is being introduced for targeted delivery of fluids to selected sites in the peripheral vascular system. The study will help physicians determine appropriate dosing of locally-delivered chemotherapy for patients with pancreatic cancer.

3 Jun 2015

New Johns Hopkins study shows re-inflating balloon after carotid stenting fuels stroke risk

After reviewing outcomes from thousands of cases, researchers at Johns Hopkins report that patients with blocked neck arteries who undergo carotid stenting to prop open the narrowed blood vessels fare decidedly worse if their surgeons re-inflate a tiny balloon in the vessel after the mesh stent is in place.

3 Jun 2015

Neutrolin post marketing surveillance data presented at 52nd ERA-EDTA Congress

CorMedix Inc., a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases, today announced a presentation on Neutrolin® post marketing surveillance data at the 52nd European Dialysis and Transplant Association (ERA-EDTA) Congress.

2 Jun 2015

Vascular surgeries provide relief from two debilitating conditions

When Carol Werkman first saw Loyola University Medical Center vascular surgeon Bernadette Aulivola, MD, she was suffering from two debilitating conditions: Every time she ate, Mrs. Werkman felt terrible abdominal pain. And whenever she walked more than a few hundred feet, her legs would begin to hurt.

1 Jun 2015

Covalon's revenue increases 24% to $1,742,672 in second quarter 2015

Covalon Technologies Ltd., an advanced medical technologies company, is delighted to announce its financial results for its second quarter ended March 31, 2015, which includes revenue for three months of $2,180,276 and net income for the quarter of $264,340.

29 May 2015

Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the initiation of CALLISTO, a new comprehensive clinical research program for their novel oral anticoagulant, rivaroxaban, in patients with active cancer. The studies are evaluating the medicine for the prevention and treatment of life-threatening blood clots in patients with a wide range of cancer types.

28 May 2015

MDLGI partners with top GI experts to expand most comprehensive gastroenterology test review service

MDLGI provides hospitals; gastroenterologists; surgeons; capsule endoscopy programs; GI clinics; as well as GERD, esophageal and reflux centers around the globe a unique ability allowing consultation with the world’s leading GI experts for detailed analyses of esophageal function testing...

19 May 2015

Clear Guide Medical signs agreement with USAISR to test effectiveness of Clear Guide ONE

Clear Guide Medical has signed a Cooperative Research and Development Agreement with the U.S. Army Institute of Surgical Research to test the physician performance enhancements possible when using the Clear Guide ONE and the VisiTIP needles.

11 May 2015

UTHealth professor awarded $1 million grant from Stryker Neurovascular for stroke research

A $1 million grant for stroke research has been awarded from Stryker Neurovascular to Amrou Sarraj, M.D., assistant professor of neurology at The University of Texas Health Science Center at Houston.

From Stryker 6 May 2015